C160545Level 6
BDR Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of bortezomib, dexamethasone, and rituximab that may be used in the treatment of Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma, Castleman disease, and mantle cell lymphoma.
**Synonyms:** - BDR - BDR - BDR (rituximab-abbs) - BDR (rituximab-arrx) - BDR (rituximab-blit) - BDR (rituximab-pvvr) - BDR (rituximab-rite) - BDR (rituximab-rixa) - BDR (rituximab-rixi) - BORID - Bortezomib-Dexamethasone-Rituximab - Bortezomib/Dexamethasone + Rituximab - Bortezomib/Dexamethasone Plus Rituximab - Bortezomib/Dexamethasone/Rituximab - Bortezomib/Dexamethasone/Rituximab Regimen - Velcade/Decadron/Rituxan
GET
/api/v1/systems/nci_thesaurus/nodes/C160545Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.